The company plans to develop more specialized, antibody-based GPCR drugs to treat a myriad of diseases. They recruited a leader in overseeing successful clinical trials to get the job done.
Small antibodies called nanobodies produced in camels, llamas, and alpacas might help stop the spread of COVID-19, but can they stand up against the competition?
The long history of insulin discovery and its development for treating diabetes is marked with determination and serendipity, collaboration and controversy.
LIVE October 26th, 2021 at 11:00 AM ET Experts will discuss recent advances in screening strategies to more efficiently identify therapeutic candidates for infectious diseases such as schistosomiasis and COVID-19.
LIVE September 22nd, 2021 at 2:30 PM ET Scientists will discuss how they identify and design new cell-based anticancer treatments and how they balance the need for potency with the specter of side effects.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.